2017 Annual Meeting

Session: Materials Science in Pharmaceutical Process Development I

Material science understanding is a key factor to consider in drug substance and drug product process development. The material properties for the API, excipients, and intermediates can influence the process and product performance. This session focuses on the application of material science to guide drug substance and drug product development. Of particular interest is work related to elucidate key material attributes impacting process and product performance as well as the application of the novel material property tool or data to gain further process understanding.

Chair

Jason Mustakis, Pfizer Inc.

Co-Chair

Lei Zhu, Merck & Co.

Presentations

08:00 AM

08:40 AM

Yu Han, Zhanjie Liu, Sara Moghtadernejad, Fernando Muzzio, Gerardo Callegari, German Drazer

09:00 AM

Manuel Kreimer, Isabella Aigner, Stephan Sacher, Markus Krumme, Thomas Mannschott, Peter van der Wel, Albert Kaptein, Hartmuth Schröttner, Günter Brenn, Johannes G. Khinast

09:20 AM

09:40 AM

Stephen L. Conway, Kenneth Rosenberg, Itzia Arroyo, Andrew Gmitter, Cindy Starbuck, Julianne Farabaugh

10:00 AM

Lei Zhu, Chengbin Huang, Yongchao Su, Gerard Klinzing, Adam Procopio, Fengyuan Yang, Jie Ren, Rubi Burlage, Anthony Leone, Lawrence Rosen